IMPDH1 and glioblastoma: Therefore, the combination of these 6 genes (CD79B, MAP2K3, IMPDH1, SLC16A3, MPZL3 and APOBR) could be regarded as a novel risk factor that might function as a prognosis indicator for GBM patients.